Does Medicare cover Trulicity?
Short answer: For type 2 diabetes, yes: Trulicity (dulaglutide) is a long-established GLP-1 covered by most Part D plans. It has no weight-loss indication and is not part of the $50 Bridge program — for weight-loss coverage, the Bridge's three products are the route.
Program facts last verified against CMS: July 21, 2026
Where Trulicity fits in 2026
Trulicity was among the first widely-used weekly GLP-1s for diabetes and remains a common formulary staple with familiar prior-authorization terms. Its weight effects are modest compared with semaglutide and tirzepatide — which is why patients whose goals have shifted toward weight loss often ask about switching. That conversation runs through your prescriber and, for coverage, through the paths this site maps: diabetes patients to the newer diabetes-indicated products on their plan's formulary; non-diabetic weight-loss candidates to the Bridge.
Take the 2-minute eligibility check →
Common questions
Can I switch from Trulicity to something stronger for weight loss?
With type 2 diabetes, your options stay on the Part D path — commonly Ozempic or Mounjaro, per your plan's formulary and your prescriber's judgment. The Bridge only serves patients without diabetes.
Is Trulicity cheaper than the $50 Bridge?
Sometimes — it's standard Part D coverage, so Extra Help and cap accumulation apply. Plan-dependent, unlike the Bridge's flat rate. (The two paths serve different diagnoses, so it's rarely an either/or choice.)
Related
Program-fact sources: CMS — Medicare GLP-1 Bridge · KFF